MedTrace Logo

Pharmacokinetics in Adolescents

NCT01196689 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2011-03-07

No results posted yet for this study

Summary

The purpose of this study is to study pharmacokinetics in adolescents.

Conditions

Interventions

DRUG

AZD1981 100 mg twice daily for 61/2 days

100 mg tablets

Sponsors & Collaborators

Principal Investigators

  • Christer Hultquist · AstraZeneca

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
17 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-02-28
Completion
2011-02-28

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01196689 on ClinicalTrials.gov